Global News

INC Research promotes Tierney to executive vice president, Asia/Pacific

Friday, March 1, 2013 02:47 PM

Therapeutically focused CRO INC Research has promoted Garth Tierney to executive vice president, Asia/Pacific, responsible for driving the strategic development and overall growth of Asia/Pacific clinical research operations. Tierney, who was INC Research’s regional general manager for Australia and Southeast Asia, co-founded Trident Clinical Research, an Australia-based CRO acquired by INC Research in 2011 after 14 years of operation.

More... »

Top technology gurus join to design mobile phone game to help speed cancer cures

Friday, March 1, 2013 02:30 PM

Cancer Research UK is bringing together its world-leading scientists with technology gurus such as Amazon Web Services, Facebook and Google to design and develop a mobile game to accelerate cures for cancer.

More... »

Medicines Patent Pool collaborates with ViiV Healthcare

Friday, March 1, 2013 12:39 PM

The Medicines Patent Pool (MPP) has launched a collaboration with ViiV Healthcare—a joint venture of GlaxoSmithKline, Pfizer and Shionogi—to facilitate greater availability of critically needed medicines for children living with HIV.

More... »

The CenterWatch Monthly, March 2013

Friday, March 1, 2013 08:00 AM

Sites rate the best sponsors 2013

More... »

Mylan to acquire Agila to create global injectables platform

Thursday, February 28, 2013 03:19 PM

Pittsburgh-based Mylan has signed a definitive agreement to acquire Agila Specialties Private Limited, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6 billion in cash.

More... »

DelMar Pharmaceuticals names Bell to board of directors

Thursday, February 28, 2013 02:34 PM

Vancouver-based DelMar Pharmaceuticals has appointed John K. Bell to the company's board of directors.

More... »

BioElectronics expands clinical research

Thursday, February 28, 2013 02:30 PM

Frederick, Md.-based BioElectronics, a maker of consumer medical devices for pain and healing, has initiated a series of new clinical trials.

More... »

Neovasc's COSIRA clinical trial protocol to be published in peer-reviewed journal

Thursday, February 28, 2013 02:27 PM

Vancouver-based Neovasc said the clinical protocol for its COSIRA (coronary sinus reducer for treatment of refractory angina) trial has been published in the peer-reviewed journal Trials. COSIRA is a double-blind, randomized, multi-center trial further assessing the efficacy and safety of the Neovasc Reducer, a novel percutaneous device for the treatment of refractory angina.  The COSIRA trial is currently enrolling patients in the U.K., Europe and  Canada. 

More... »

Roche launches process for accessing clinical trial data

Thursday, February 28, 2013 02:24 PM

Basel, Switzerland-based Roche is expanding access to its clinical trial data for third-party researchers. Roche will work with an independent body of recognized experts to evaluate and approve requests to access anonymized patient-level data.

More... »

Jazz, Concert partner to develop deuterium-modified sodium oxybate

Wednesday, February 27, 2013 11:54 AM

Jazz Pharmaceuticals, an Irish specialty biopharmaceutical company focused on unmet medical needs, and Concert Pharmaceuticals, a Lexington, Mass.-based clinical stage biotechnology company, have signed an exclusive license agreement that provides Jazz Pharmaceuticals worldwide rights to develop and commercialize Concert's deuterium-modified sodium oxybate (D-SXB) compounds, including C-10323.   

More... »